The Maria Sklodowska-Curie National Research Institute of Oncology is a specialized research institute and hospital of the Polish Ministry of Health. Based in Warsaw, it also has regional branches in Gliwice and Kraków.

During the past decade, Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 8 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator, "Onxeo" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego" are "Peripheral T-cell Lymphoma" (3 trials), "Adult Solid Tumor" (1 trials), "B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion" (1 trials), "Breast Cancer" (1 trials) and "Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego" in a lesser frequency.

Most popular intervention types in "Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (6 trials), "Idelalisib" (2 trials), "Obinutuzumab" (2 trials), "Atezolizumab [TECENTRIQ]" (1 trials) and "Belinostat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".